Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin,  Celadon, Conroy, Caracal, Evgen,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Thursday 2nd March 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Angus, Aterian, Blu,
RNS Hotlist with Zak Mir: GGP, GLR, BANK, RENE, BRSD, HZM, PANR, BMV, BVC, EISB, INSP, TERN, MAST & EVG via Vox Markets
Greatland Gold (GGP), the mining development and exploration company, provided an exploration and development update at the Havieron gold-copper project in the Paterson region of Western Australia.
Traders Cafe with Zak Mir: Bulletin Board Heroes, Wednesday 30th November 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is  FTSE 100, DAX 40, Dow, Bitcoin,
RNS Hotlist with Zak Mir: QTZ, RGO, SEE, DOTD, INCE, CRTM, EST, CRCL, KMK, EVG, THX, PMG, GST, BEM & ENET via Vox Markets
Quetzal Capital (QTZ), which has conditionally agreed to acquire Tap Global Limited, a regulated, crypto-fiat exchange service provider, notes recent developments in cryptocurrency markets concerning FTX Group and questions around
Evgen Pharma PLC (AIM:EVG) Study started of new SFX-01 tablet formulation
First healthy volunteers dosed on schedule
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 8th November 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax, Dow, Bitcoin, Aston,
RNS Hotlist with Zak Mir: DVRG, IES, AGL, I3E, SLE, BION, KIST, SAR, CCZ, HSW, ANGS, EVG, EST & DKE
DeepVerge (DVRG) said it notes recent market speculation regarding forthcoming loan repayments and a potential equity fundraising.
RNS Hotlist with Zak Mir: EVG, HUI, MSMN, I3E, DKL, ZPHR, HE1, JAY, QUIZ, ORR & THR
Evgen Pharma (EVG), a clinical-stage drug development company, has licensed the global rights for lead asset SFX-01 in neurodevelopmental disorders and schizophrenia to Stalicla SA, a Swiss company specialising in
Evgen Pharma PLC (AIM:EVG) SFX-01 licensing deal for up to $160.5m
SFX-01 licensing deal for up to $160.5m in milestone payments expands lead asset into neurodevelopmental disorders
Evgen Pharma PLC (EVG.L) Progress with UK and US regulators for 2022 trials
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane based medicines for the treatment of cancers and inflammation, announces that it has progressed discussions with the